| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,283 |
20,720 |
$976K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,907 |
5,519 |
$263K |
| 87428 |
|
4,148 |
3,384 |
$242K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,518 |
12,042 |
$183K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,661 |
3,933 |
$170K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,713 |
5,324 |
$162K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,081 |
1,923 |
$152K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,937 |
1,777 |
$146K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,555 |
4,189 |
$105K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,373 |
1,311 |
$103K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,309 |
1,196 |
$101K |
| S8301 |
Infection control supplies, not otherwise specified |
10,173 |
8,071 |
$69K |
| 87807 |
|
6,089 |
5,080 |
$62K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,788 |
7,534 |
$53K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
563 |
515 |
$30K |
| 90461 |
|
2,697 |
2,093 |
$11K |
| 99381 |
|
81 |
76 |
$6K |
| 81003 |
|
2,561 |
2,252 |
$4K |
| 0071A |
|
119 |
100 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
77 |
63 |
$4K |
| 99050 |
|
248 |
211 |
$3K |
| 0001A |
|
65 |
60 |
$2K |
| 99382 |
|
24 |
24 |
$2K |
| 99000 |
|
189 |
181 |
$2K |
| 99051 |
|
483 |
440 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
37 |
$2K |
| 0072A |
|
49 |
44 |
$2K |
| 0002A |
|
33 |
32 |
$1K |
| 99384 |
|
13 |
13 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
880 |
768 |
$296.65 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
13 |
$145.09 |
| 90686 |
|
259 |
251 |
$63.18 |
| 90658 |
|
650 |
589 |
$21.45 |
| 90734 |
|
112 |
104 |
$1.00 |
| 91300 |
|
232 |
194 |
$0.00 |
| 90670 |
|
1,219 |
1,148 |
$0.00 |
| 90648 |
|
679 |
638 |
$0.00 |
| 90710 |
|
122 |
112 |
$0.00 |
| 90633 |
|
308 |
300 |
$0.00 |
| 90715 |
|
68 |
65 |
$0.00 |
| 90700 |
|
14 |
13 |
$0.00 |
| 90707 |
|
12 |
12 |
$0.00 |
| 90680 |
|
638 |
606 |
$0.00 |
| 90696 |
|
69 |
66 |
$0.00 |
| 90723 |
|
265 |
250 |
$0.00 |
| 91307 |
|
188 |
164 |
$0.00 |
| 90651 |
|
95 |
88 |
$0.00 |
| 90620 |
|
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$0.00 |
| 90698 |
|
14 |
12 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 90697 |
|
17 |
17 |
$0.00 |